Teva Pharmaceutical Industries
124 Dvora HaNevi'a Street, Tel Aviv, 6944020, Israel
Overview
Teva Pharmaceuticals is a pharmaceutical company specializing in the development, production, and marketing of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Biopharma
- Health Care
- Medical
- Pharmaceutical
Investment portfolio
- Cocrystal Discovery
Led · Equity · Sep 2011
Cocrystal Discovery focuses on discovering and developing novel antiviral therapeutics that inhibit viral replication enzymes, with programs targeting hepatitis C, influenza and rhinovirus. The company employs atomic-level structure determination, including high-resolution X-ray crystallography, combined with advanced computational methods to design first- and best-in-class small-molecule inhibitors. CDI is developing oral, once-a-day, broad-spectrum antivirals aimed at treating serious and chronic viral diseases. The company is privately funded and will use the incoming investment to continue its development programs. CDI’s stated mission is to discover and develop oral inhibitors of the viral replication complex and to expand its platform to address viral and other diseases. Headquarters are in Bothell, Washington, with laboratories in Bothell and Mountain View, California.
Team
No current team members are available.